Member Exclusive News

Novel drug candidate could treat visceral leishmaniasis

Collaborative research between the University of Dundee, GSK and Wellcome has uncovered a new preclinical drug candidate that could treat one of the world’s major neglected diseases.

Jul 27, 2018

Please sign in or register for FREE

No comments yet.